NI
CLX icon

Nuance Investments’s Clorox CLX Stock Holding History

Nuance Investments’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.5M Buy
528,738
+20,593
+4% +$1.98M 8.59% 3
2026
Q1 		$52.7M Sell
508,145
-278,644
-35% -$31.6M 7.34% 4
2025
Q4 		$79.3M Buy
786,789
+91,972
+13% +$9.98M 8.74% 1
2025
Q3 		$85.7M Sell
694,817
-153,289
-18% -$19M 8.72% 1
2025
Q2 		$102M Buy
848,106
+547,839
+182% +$73.1M 7.93% 1
2025
Q1 		$44.2M Sell
300,267
-58,845
-16% -$8.99M 2.9% 13
2024
Q4 		$58.3M Sell
359,112
-516,882
-59% -$84.6M 2.35% 16
2024
Q3 		$143M Sell
875,994
-721,680
-45% -$107M 4.79% 7
2024
Q2 		$218M Buy
1,597,674
+960,094
+151% +$133M 6.66% 3
2024
Q1 		$97.6M Sell
637,580
-444,195
-41% -$66.3M 2.56% 13
2023
Q4 		$154M Sell
1,081,775
-244,014
-18% -$32.5M 3.53% 9
2023
Q3 		$174M Buy
1,325,789
+271,133
+26% +$41.2M 4.26% 10
2023
Q2 		$168M Sell
1,054,656
-202,707
-16% -$32.7M 3.59% 10
2023
Q1 		$199M Sell
1,257,363
-493,014
-28% -$73.9M 4.21% 9
2022
Q4 		$246M Buy
1,750,377
+298,692
+21% +$42.4M 5.14% 7
2022
Q3 		$186M Buy
1,451,685
+223,818
+18% +$32.3M 4.15% 11
2022
Q2 		$173M Buy
1,227,867
+85,504
+7% +$12.2M 3.44% 11
2022
Q1 		$159M Buy
1,142,363
+790,505
+225% +$121M 2.84% 15
2021
Q4 		$61.4M Buy
351,858
+251,543
+251% +$41.9M 1.08% 28
2021
Q3 		$16.6M Buy
+100,315
New +$17.3M 0.3% 40
2020
Q1 		– Sell
-45,547
Closed -$7M – 63
2019
Q4 		$7M Buy
+45,547
New +$6.81M 0.23% 44
2018
Q4 		– Sell
-42,291
Closed -$6.36M – 63
2018
Q3 		$6.36M Buy
42,291
+4,050
+11% +$575K 0.38% 46
2018
Q2 		$5.17M Sell
38,241
-206,593
-84% -$25.5M 0.34% 48
2018
Q1 		$32.6M Sell
244,834
-2,552
-1% -$343K 2.2% 17
2017
Q4 		$36.8M Buy
247,386
+222,871
+909% +$30.3M 2.46% 17
2017
Q3 		$3.23M Buy
24,515
+2,487
+11% +$334K 0.22% 73
2017
Q2 		$2.94M Buy
+22,028
New +$2.97M 0.22% 75

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nuance Investments's CLX Position: Q2 2026 in Review

Nuance Investments increased its Clorox (CLX) stake by 4.1% in Q2 2026, buying an estimated $1.98M and bringing the position to 528,738 shares worth $50.5M. The position accounts for 8.59% of the portfolio, ranked #3.

Nuance Investments first reported a position in CLX in Q2 2017 and has held it in 27 quarters since. The position peaked at $246M in Q4 2022. 1,044 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Nuance Investments held 528,738 shares of Clorox worth $50.5M as of Q2 2026.
  • Nuance Investments bought 20,593 Clorox shares in Q2 2026, an estimated $1.98M.
  • Clorox made up 8.59% of Nuance Investments's portfolio in Q2 2026, its #3 holding.
  • Nuance Investments first reported a position in Clorox in Q2 2017 and has held it in 27 quarters since.
  • Nuance Investments's Clorox position peaked at $246M in Q4 2022.
  • 1,044 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Nuance Investments's 13F filing for Q2 2026, filed 7 Aug 2026.